Specialization
Focus of research
Regulatory science, rare diseases, orphan drugs
-
Medicine Development and Access for Rare Diseases: Can We Do Better?
Hollak, C. E. M., Rosenberg, N., Post, C., Stolwijk, N., Manders, E., Schoenmakers, D., Penninx, B., Reijnhout, N., Verdeyen, K., Jonker, R., Bosch, A. M., Langeveld, M., van der Wel, V., de Visser, S. & van den Berg, S., Mar 2026, In: Journal of inherited metabolic disease. 49, 2, p. e70146 e70146.Research output: Contribution to Journal › Review article › Academic › peer-review
-
Drivers of managed entry agreements to reduce reimbursement challenges of orphan medicinal products: the development of a matrix
Callenbach, M. H. E., van den Berg, S., Hulsbosch, A., Hollak, C. E. M., Leopold, C., Mantel-Teeuwisse, A. K. & Goettsch, W. G., 1 Dec 2025, In: Orphanet Journal of Rare Diseases. 20, 1, 540.Research output: Contribution to Journal › Article › Academic › peer-review
-
Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products
van den Berg, S., Hollak, C. E., Timmers, L. & de Visser, S. J., May 2025, In: Value in Health. 28, 5, p. 692-698 7 p.Research output: Contribution to Journal › Article › Academic › peer-review
- All publications